Between 2018 and 2023, Dr Ivan Puah treated over 550 cases, addressing unique challenges in Singapore's multi-ethnic population. His study included diverse case profiles....
KANSAS CITY, Mo., June 2, 2026 /PRNewswire/ -- Andrews McMeel Publishing (AMP) announces the release of A Court of Thorns and Roses 2027 Calendars from the blockbuster Sarah J....
MARTINSVILLE, Ind., June 2, 2026 /PRNewswire/ -- In conjunction with the bipartisan Congressional Camp Caucus, the American Camp Association (ACA) will convene congressional leaders, camp...
Mobility Direct Releases Comprehensive State-by-State Research Resource Examining Mobility Scooter Regulations, Accessibility Rules, and Public Guidance Across the United StatesDEERFIELD BEACH, Fla., June 2,...
While 70% of consumers trust nonprofit credit counseling, nearly half are unaware of the most effective solution for the $1.3 trillion national debt crisis:...
ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it completed its acquisition of Family First Holding, LLC ("Family First Homecare").
Partnership with the Belgian Red Devils marks a major step in Yozma's global brand evolution.LULEÅ, Sweden, June 2, 2026 /PRNewswire/ -- To mark its first...
Saint Herblain (France), August 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that Health Canada has granted marketing authorization for its single-dose vaccine, IXCHIQ®, for the prevention of disease caused by the chikungunya virus in individuals aged 12 years and older. This announcement adds to the adult marketing authorization already received in Canada1 and complements the adolescent label extension received in Europe in April 20252.